Status:
COMPLETED
PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
COVID
ARDS
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The COVID epidemics is responsible for a huge number of death following COVID acute respiratory failure. First instance treatment includes oxygenotherapy up to 15L/min in spontaneous ventilation. Howe...
Detailed Description
Patients admitted to the hospital with laboratory-confirmed SARS-CoV-2 infection as determined by PCR and/or CT scan showing typical radiological findings (ground glass abnormalities) and requiring O2...
Eligibility Criteria
Inclusion
- Patients admitted to the hospital
- Laboratory-confirmed SARS-CoV-2 infection as determined by PCR and/or CT scan showing typical radiological findings (ground glass abnormalities)
- Need for O2 3L/min to get an SpO2 higher or equal to 95%.
- Patient able to understand and to get in prone postion themself
- No therapeutic limitation
Exclusion
- Age \> 80 years
- Pregnancy
- Impossibility to get in prone position
Key Trial Info
Start Date :
June 26 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 23 2021
Estimated Enrollment :
446 Patients enrolled
Trial Details
Trial ID
NCT04366856
Start Date
June 26 2020
End Date
September 23 2021
Last Update
December 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Département d'Anesthésie Réanimation - Kremlin Bicêtre
Le Kremlin-Bicêtre, France, 94270